CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B
Won Sohn, Ju-Yeon Cho, Ji Hoon Kim, Jung Il Lee, Hyung Joon Kim, Min-Ah Woo, Sin-Ho Jung, Yong-Han Paik
Clin Mol Hepatol. 2017;23(2):170-178.   Published online 2017 May 16    DOI: https://doi.org/10.3350/cmh.2016.0086

Excel Download

Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B
Clinical and Molecular Hepatology. 2017;23(2):170-178   Crossref logo
Link1 Link2 Link3

Lower risk of hepatocellular carcinoma with tenofovir than entecavir in antiviral treatment-naïve chronic hepatitis B patients: a systematic review and meta-analysis involving 90,897 participants
Clinical and Experimental Medicine. 2023;   Crossref logo
Link1 Link2 Link3

Reply to: “Individual surveillance using model-based hepatocellular carcinoma risk estimates in chronic hepatitis C patients after antiviral treatment”
Journal of Hepatology. 2019;70(1):211-212   Crossref logo
Link1 Link2

Changes of enhanced liver fibrosis score predict hepatocellular carcinoma in chronic hepatitis B patients receiving antiviral treatment
Journal of Hepatology. 2022;77:S302   Crossref logo
Link1 Link2

Active Antiviral Treatment for Chronic Hepatitis C Virus Infection Needs to be Recommended for Decreasing Hepatitis C-Associated Hepatocellular Carcinoma Risk in the New Era of Highly Effective Oral Antiviral Drugs
Journal of Hepatology. 2016;64(2):S830   Crossref logo
Link1 Link2

Assessment of Liver Stiffness Regression and Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients after Treatment with Direct-Acting Antiviral Drugs
Medicina. 2021;57(3):210   Crossref logo
Link1

Association of Hepatocellular Carcinoma Risk with Baseline Viral Load in HBeAg-positive Chronic Hepatitis B Patients under Antiviral Treatment
The Korean Journal of Gastroenterology. 2022;80(3):161-162   Crossref logo
Link1 Link2

44 PERFORMANCE OF HEPATOCELLULAR CARCINOMA RISK SCORES IN CHRONIC HEPATITIS B PATIENTS RECEIVING ENTECAVIR TREATMENT
Journal of Hepatology. 2013;58:S19   Crossref logo
Link1 Link2

In patients under treatment, chronic hepatitis D is a greater risk factor for hepatocellular carcinoma development than chronic hepatitis B
Journal of Hepatology. 2017;66(1):S687-S688   Crossref logo
Link1 Link2

Risk of hepatocellular carcinoma in treatment‐naïve chronic hepatitis B patients receiving tenofovir disoproxil fumarate versus entecavir in the United States
Alimentary Pharmacology & Therapeutics. 2022;55(7):828-835   Crossref logo
Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.